A fracture does not adversely affect bone mineral density responses after teriparatide treatment (Q35723052)

9 August 2017

title

A fracture does not adversely affect bone mineral density responses after teriparatide treatment (English)

1 reference

9 August 2017

Aasis Unnanuntana

1 reference

9 August 2017

Quang V Ton

1 reference

9 August 2017

John P Kleimeyer

1 reference

9 August 2017

Joseph T Nguyen

1 reference

9 August 2017

Joseph M Lane

1 reference

9 August 2017

language of work or name

English

0 references

publication date

24 August 2011

1 reference

Clinical Orthopaedics and Related Research

9 August 2017

published in

1 reference

9 August 2017

volume

470

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

927-936

1 reference

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Trauma-induced inflammation and fracture healing.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Bone-turnover markers in fracture healing

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

When is a fracture healed? Radiographic and clinical criteria revisited

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Long-term use of bisphosphonates in osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Hip fractures among elderly women: longitudinal comparison of physiological function changes and health care utilization

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Osteoporosis: management and treatment strategies for orthopaedic surgeons.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Biochemical markers of bone turnover: part I: biochemistry and variability

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Protein depletion and metabolic stress in elderly patients who have a fracture of the hip.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Changes in protein synthesis after trauma: importance of nutrition

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

Factors influencing the treatment of osteoporosis following fragility fracture

12 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Changes in total alkaline phosphatase level after hip fracture: comparison between femoral neck and trochanter fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Protein and energy balance following femoral neck fracture in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Changes in bone mass and bone turnover following tibial shaft fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-2029-1

Metabolic rate and nitrogen balance after skeletal trauma in female and male rats.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270178

[Biochemical markers of bone turnover. New aspect. Changes in bone turnover markers during fracture healing]

25 September 2018

1 reference

12 December 2020

Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells

1 reference

12 December 2020

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

1 reference

12 December 2020

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

12 December 2020

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

1 reference

12 December 2020

Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing

1 reference

12 December 2020

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

1 reference

12 December 2020

Types I and III procollagen extension peptides in serum respond to fracture in humans

1 reference

12 December 2020

Dietary protein supplementation and recovery from femoral fracture

1 reference

12 December 2020

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

1 reference

12 December 2020

Metabolic studies in multiple injured patients. Clinical features, routine chemical analyses and nitrogen balance

1 reference

12 December 2020

Nitrogen requirements in severely injured patients

1 reference

12 December 2020

Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study

1 reference

12 December 2020

In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats

1 reference

12 December 2020

Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Changes in biochemical markers after lower limb fractures

1 reference

12 December 2020

Parathyroid hormone enhances fracture healing. A preliminary report

1 reference

12 December 2020

10.1007/S11999-011-2029-1

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference